In the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
Others have stated their priorities directly with Federal Government. Through these interviews, AHJ gives a final opportunity to communicate to all health stakeholders, the funding needs for a range of priorities. These range from new models of care to pilots and wholesale, system improvements to building more sustainable workforces to help grow certain sectors of the health system
The Chief Executive Officer of The Australasian College of Paramedicine, John Bruning spoke with Australian Health Journal about the following:
- New models of care proposed for paramedics
- Paramedicine pilot program in the pre-budget submission
- Scope of how paramedics can support General Practice, and guidelines on safety and quality
- Current limitations experienced by paramedics needing to be addressed by Government
Lastly John talks about other priorities he hopes are included in the Federal Budget. These include a longer term, widespread reform view of the health system. There has been an approach where things have been “added on, gaps filled, issues identified” in 3-4 year cycles. John hopes there is a direction taken where health is completely reformed, including in access for regional, remote and 1st nations people. John sees the public needing further guidance and awareness on the health system to support public health literacy.
Finally cultural training is needed to deliver safe and appropriate health care to the range of diverse populations that clinicians serve. This can lead to fulfilling and purposeful workforce, which in itself needs the Government to consider the wellbeing aspects of clinicians during very challenging times in the pandemic.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
-
Connected Health Systems
Challenges in health care delivery have compounded, with clinical staff being exposed to the Omicron COVID variant. Reduced staffing has brought on its challenges to most already-strained state health care systems and the people working in them.
However, over the past 2 years of the pandemic, technology has played an increasing role on the front end for patients and consumers at home and clinicians in the medical setting. Much more is planned in technology that will deliver efficiency, reduce risk and make available new models of care. This has the potential to touch the working lives of all stakeholders and recipients of care.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
